8-K
Current Report
IONIS PHARMACEUTICALS INC Filed Acc 0001140361-21-011725
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading brhc10022825_8k.htm…